secwatch / observer
8-K filed July 18, 2023, 7:59 PM ET ticker RPID CIK 0001380106
leadership confidence high sentiment neutral materiality 0.55

Rapid Micro Biosystems appoints Kirk Malloy as Chair of Board, expands board to eight

RAPID MICRO BIOSYSTEMS, INC.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Jeffrey Schwartz

Chair of the Board
RPID · RAPID MICRO BIOSYSTEMS, INC.
Effective
2023-07-14
Successor
Kirk D. Malloy
Filed
July 18, 2023, 7:59 PM ET
Jeffrey Schwartz resigned as Chair of the Board as of the Effective Date and will continue to serve as a member of the Board.
Appointed

Kirk D. Malloy

Chair of the Board
RPID · RAPID MICRO BIOSYSTEMS, INC.
Effective
2023-07-14
Filed
July 18, 2023, 7:59 PM ET
appointed Kirk D. Malloy, Ph.D. to serve as a Class III member of the Board and Chair of the Board, effective as of July 14, 2023 (the “Effective Date”).

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Jeffrey Schwartz resigned as Chair of the Board at RAPID MICRO BIOSYSTEMS, INC..

Action
resigned
Role
Chair of the Board
Exact text from the filing
Jeffrey Schwartz resigned as Chair of the Board as of the Effective Date and will continue to serve as a member of the Board.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Kirk D. Malloy was appointed as Chair of the Board at RAPID MICRO BIOSYSTEMS, INC..

Action
appointed
Role
Chair of the Board
Exact text from the filing
appointed Kirk D. Malloy, Ph.D. to serve as a Class III member of the Board and Chair of the Board, effective as of July 14, 2023 (the “Effective Date”).
View on SEC.gov

RAPID MICRO BIOSYSTEMS, INC. filing history →

Source: SEC EDGAR
accession 0001380106-23-000130
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.